← Back to All Filings

Vanguard Group Reports 0% Stake in CME Group Due to Internal Realignment

Low SignificanceMarch 26, 2026 at 2:26:02 PM EDT

CME GROUP INC.

$CMESCHEDULE 13G/ACIK: 0001156375

Subscribe to track CME

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Group Reports 0% Stake in CME Group Due to Internal Realignment

Company: CME Group Inc. Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Investor: The Vanguard Group Relationship: Institutional Manager

Filing Details: • Shares Reported: 0 • Ownership: 0% • Previous Status: >5% Owner

Key Insight: Vanguard reports 0 shares due to an internal realignment. Subsidiaries will now report beneficial ownership separately. This does not necessarily indicate a market sale of the underlying assets.

Market Context: CME Group is a Large Cap entity ($110.21B). This filing represents a change in reporting structure rather than a change in market sentiment.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: CME Group Inc.

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an internal corporate realignment where subsidiaries will now report separately; this is likely not a liquidation event.
  • Market Impact: Neutral - The change is administrative/regulatory rather than transactional.

Company Information

FieldValue
CompanyCME Group Inc.
CIK0001156375
Market Cap$110.21 Billion
Shares Outstanding358,620,000

Insider Information

FieldValue
NameThe Vanguard Group
CIK0000102909
RelationshipInstitutional Advisor

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Filing Date2026/03/26
Shares Reported0
Ownership %0%
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

MetricValue
Shares TransactedN/A (Reporting Change)
% of Shares Outstanding0% (Current Report)
Post-Transaction Ownership0 shares (0% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: As a $110.21B Large Cap company, CME Group has high institutional liquidity.
  • Ownership Concentration: While Vanguard is historically a major holder, this specific filing reduces the parent company's reported direct aggregation to zero.
  • Transaction Significance: The filing explicitly states: "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries." This confirms the drop to 0% is technical, not a market exit.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing contains a specific footnote regarding "internal realignment" and reliance on SEC Release No. 34-39538. Investors should not interpret this as a bearish signal or a massive sell-off.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Special Circumstances: On January 12, 2026, Vanguard underwent a realignment. Subsidiaries now report separately. This filing (Amendment No. 10) closes out the parent company's aggregated reporting for this security.
Topics:#SECFiling#CMEGroup#Vanguard#InstitutionalOwnership#Form13G#StockMarket#FinancialAnalysis#RegulatoryFiling

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.